chlortetracycline

chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with chlortetracycline?

chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with chlortetracycline

MeSH term MeSH ID Detail
Theileriasis D013801 7 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Clostridium Infections D003015 5 associated lipids
Syphilis, Latent D013592 4 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Pharyngeal Diseases D010608 4 associated lipids
Eyelid Diseases D005141 4 associated lipids
Dysentery D004403 4 associated lipids
Digital Dermatitis D058066 3 associated lipids
Impetigo D007169 3 associated lipids
Per page 10 20 50 | Total 49

PubChem Associated disorders and diseases

What pathways are associated with chlortetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with chlortetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with chlortetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with chlortetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with chlortetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with chlortetracycline?

Mouse Model

Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with chlortetracycline

Download all related citations
Per page 10 20 50 100 | Total 4669
Authors Title Published Journal PubMed Link
BRYER MS and SCHOENBACH EB The treatment of acute brucellosis with aureomycin. 1949 Bull Johns Hopkins Hosp pmid:18120064
BERESTON ES and CARLINER PE The treatment of a case of Kaposi's varicelliform eruption with aureomycin. 1949 J. Invest. Dermatol. pmid:18133468
FULLER FW and FAUST EC Aureomycin in the cultivation of Endamoeba histolytica. 1949 Science pmid:15390469
DOWLING HF and LEPPER MH Aureomycin in various infections; report of 180 cases and review of the clinical literature. 1949 Med Ann Dist Columbia pmid:18133899
PENALVER BALLINA R [Not Available]. 1949 Bol Soc Cubana Dermatol Sifilogr pmid:18134648
FISHER AA and SCHWARTZ S Stomatitis ulceromembranosa acuta treated with aureomycin. 1949 J. Invest. Dermatol. pmid:18134650
FINLAND M and COLLINS HS Present status of aureomycin therapy. 1949 Ann. Intern. Med. pmid:18134809
DeROETTH A Penetration of aureomycin into the eye. 1949 Arch Ophthal pmid:15396857
ALLEN AW and RIECKER HH Bacterial endocarditis caused by a hemolytic Staphylococcus albus treated with aureomycin. 1949 J Mich State Med Soc pmid:15396940
TONDI IV [Not available]. 1949 Policlinico Prat pmid:24536686
DE WIT JC [Not Available]. 1949 Geneeskd Gids pmid:18228811
APPELMAN HB and HALE AS Aureomycin in dendritic keratitis; case report. 1949 J Mich State Med Soc pmid:18113957
ANIGSTEIN L et al. Aureomycin; protective effect in experimental Rocky Mountain spotted fever and typhus with particular reference to intermittent treatment. 1949 Tex. Rep. Biol. Med. pmid:18114264
HERRELL WE and HEILMAN FR Aureomycin studies on absorption, diffusion and excretion. 1949 Proc Staff Meet Mayo Clin pmid:18115523
SEED JC and WILSON CE Fluorometric determination of serum aureomycin levels. 1949 Science pmid:15397439
CHANDLER CA et al. Observations on staphylococcal infections treated with aureomycin. 1949 Pediatrics pmid:18137836
WRIGHT LT and METZGER WI Treatment of acute peritonitis with aureomycin. 1949 Am. J. Surg. pmid:18152990
LEVINE J et al. The chemical assay of aureomycin. 1949 J Am Pharm Assoc Am Pharm Assoc pmid:18137887
SCARZELLA M et al. [Not Available]. 1949 Minerva Med. pmid:18146356
BOUYQUES P [Not Available]. 1949 Paris Med pmid:18146676
WOODWARD TE Chloromycetin and aureomycin; therapeutic results. 1949 Ann. Intern. Med. pmid:18146884
GRATER WC and RIDER JA Lymphocytic choriomeningitis; treatment of two cases with aureomycin. 1949 Tex State J Med pmid:18147033
DISTELHEIM IH and SULZBERGER MB Aureomycin employed locally in painful mouth ulcerations; stomatitis aphthosa or periadentitis mucosa necrotica recurrens. 1949 J. Invest. Dermatol. pmid:18147173
WILLCOX RR and FINDLAY GM Urethritis, gonococcal and nonspecific, treated by aureomycin. 1949 Br Med J pmid:18147222
DI GANGI FE and ROGERS CH Adsorption studies of aureomycin hydrochloride on aluminum hydroxide gel. 1949 J Am Pharm Assoc Am Pharm Assoc pmid:15398560
TROUTMAN EG and FLESHER MO Aureomycin; a review. 1949 Univ South Calif Bull Sch Med pmid:18137622
DE GENNES L and BRICAIRE H [Not Available]. 1949 Presse Med pmid:18118740
LONG PH The present status of polymyxin, chloromycetin and aureomycin; experimental and clinical. 1949 Am J Pharm Sci Support Public Health pmid:18118956
JUKES RF Aureomycin in infections of the urinary tract. 1949 Ohio Med pmid:18119525
PRICE CW et al. Bacteriological studies of aureomycin. 1948 Ann. N. Y. Acad. Sci. pmid:18124196
PAINE TF et al. Laboratory studies with aureomycin. 1948 Ann. N. Y. Acad. Sci. pmid:18124197
STEARNS CM First effective weapon against Q fever, typhus, and spotted fever is aureomycin; it may become best drug of decade. 1948 Sci Illus pmid:18884645
AUREOMYCIN in virus diseases. 1948 Am Prof Pharm pmid:18885599
BRYER MS and SCHOENBACH EB Aureomycin; experimental and clinical investigations. 1948 J Am Med Assoc pmid:18879285
WRIGHT LT and SANDERS M Aureomycin; a new antibiotic with virucidal properties; a preliminary report on successful treatment in 25 cases of lymphogranuloma venereum. 1948 J Am Med Assoc pmid:18883232
BRALEY AE and SANDERS M Aureomycin in ocular infections; a preliminary report. 1948 J Am Med Assoc pmid:18883235
COOKE C Rocky Mountain spotted fever treated with aureomycin. 1948 J Am Med Assoc pmid:18890443
MEADS M et al. In vitro observations on the antibacterial activity of aureomycin. 1948 N C Med J pmid:18890720
FINLAND M et al. Aureomycin, a new antibiotic; results of laboratory studies and of clinical use in 100 cases of bacterial infections. 1948 J Am Med Assoc pmid:18892416
GREENBLATT RB and DIENST RB Oral aureomycin in the therapy of streptomycin-resistant granuloma inguinale. 1948 South. Med. J. pmid:18892826
Paine TF et al. Bacteriologic Studies on Aureomycin. 1948 J. Bacteriol. pmid:16561597
COLLINS HS and PAINE TF Aureomycin; a new antibiotic; evaluation of its effects in typhoid fever, severe salmonella infections and in a case of colon bacillus bacteremia. 1948 Ann. Intern. Med. pmid:18100407
COLLINS HS et al. Aureomycin in treatment of pneumococcal pneumonia and meningococcemie. 1948 Proc. Soc. Exp. Biol. Med. pmid:18102197
ROSS S and SCHOENBACH EB Aureomycin therapy of Rocky Mountain spotted fever. 1948 J Am Med Assoc pmid:18103383
BRYER MS and SCHOENBACH EB Treatment of experimental infections with aureomycin. 1948 Ann. N. Y. Acad. Sci. pmid:18124199
DOWLING HF and LEPPER MH Studies on serum concentrations in humans and preliminary observations on the treatment of human infections with aureomycin. 1948 Ann. N. Y. Acad. Sci. pmid:18124198
LENNETTE EH et al. Treatment of Q fever in man with aureomycin. 1948 Ann. N. Y. Acad. Sci. pmid:18112238
WRIGHT LT and SANDERS M The treatment of lymphogranuloma venereum and granuloma inguinale in humans with aureomycin. 1948 Ann. N. Y. Acad. Sci. pmid:18112237
ANIGSTEIN L et al. Aureomycin, a new antibiotic with antirickettsial properties; its effect on experimental spotted fever and epidemic typhus. 1948 Ann. N. Y. Acad. Sci. pmid:18112236
WONG SC and COX HR Action of aureomycin against experimental rickettsial and viral infections. 1948 Ann. N. Y. Acad. Sci. pmid:18112235